AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7835118 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 3293642 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.2 ml (0.2 mg) with 5% lignocaine 2 ml in 7.5% dextrose
Number of subjects: 60
Study 3293642 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.4 ml with 5% lignocaine 2 ml in 7.5% dextrose
Number of subjects: 60
Study 3293642 — intervention group
Group type: COMPARATOR
Intervention: 5% lignocaine 2 ml in 7.5% dextrose with physiological saline 1 ml
Number of subjects: 60
Study 31838113 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy at 6 l/min for 6 to 12 hours
Number of subjects: 5010
Study 31838113 — intervention group
Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 5010
Study 31838113 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 5010
Study 30384961 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion dysregulation
Number of subjects: 188
Study 28382673 — intervention group
Group type: EXPERIMENTAL
Intervention: X:IT intervention (medium implementation)
Number of subjects: 49
Study 28382673 — intervention group
Group type: EXPERIMENTAL
Intervention: X:IT intervention (high implementation)
Number of subjects: 49
Study 26033271 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training Group (FTG)
Number of subjects: 29
Study 26033271 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 29
Study 23801029 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon osteoplasty
Number of subjects: 24
Study 23801029 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods of fracture reduction
Number of subjects: 24
Study 22858814 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based handrubs (ABH)
Number of subjects: 1727
Study 22858814 — intervention group
Group type: COMPARATOR
Intervention: Existing handwashing practices (control)
Number of subjects: 1727
Study 19950305 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment for fibromyalgia
Number of subjects: 0
Study 17242147 — intervention group
Group type: EXPERIMENTAL
Intervention: Apricitabine at 600 mg twice daily
Number of subjects: 21
Study 17242147 — intervention group
Group type: EXPERIMENTAL
Intervention: Apricitabine at 600 mg twice daily with lamivudine at 300 mg once daily
Number of subjects: 21
Study 17242147 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine at 300 mg once daily
Number of subjects: 21
Study 15735187 — intervention group
Group type: EXPERIMENTAL
Intervention: iTCC (removable cast walker rendered irremovable)
Number of subjects: 41
Study 15735187 — intervention group
Group type: COMPARATOR
Intervention: TCC (total contact cast)
Number of subjects: 41
Study 15735187 — intervention group
Group type: EXPERIMENTAL
Intervention: iTCC
Number of subjects: 41
Study 15735187 — intervention group
Group type: COMPARATOR
Intervention: TCC
Number of subjects: 41
Study 11987981 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study 11987981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9821566 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive information
Number of subjects: 50
Study 9821566 — intervention group
Group type: COMPARATOR
Intervention: Control manipulation
Number of subjects: 50
Study 9821566 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline partial pressure of CO2
Number of subjects: 50
Study 9821566 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety sensitivity
Number of subjects: 50
Study 8009342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal oxytocin (ED50 0.172 micrograms/kg in chronic pain, 0.121 micrograms/kg in acute pain)
Number of subjects: 0
Study 8009342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal oxytocin (ED50 0.067 micrograms/kg in rats)
Number of subjects: 0
Study 8009342 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of oxytocin (ED50 17.915 micrograms/kg)
Number of subjects: 0
Study 8009342 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of oxytocin (LD50 27.224 micrograms/kg)
Number of subjects: 0
Study 8009342 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin antagonist [d(CH2)5, Tyr(Me)2, Orn8]-vasotocin
Number of subjects: 0
Study 8009342 — intervention group
Group type: COMPARATOR
Intervention: Opiate receptor-blocker naloxone
Number of subjects: 0
Study 8009342 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0
Study 8009342 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin antagonist
Number of subjects: 0
Study 2691131 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 34
Study 2691131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30722727 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI training with voluntary desynchronization of ipsilesional EEG-sensorimotor rhythms triggering paretic upper-limb movements via robotic orthoses (experimental group, n = 16)
Number of subjects: 28
Study 30722727 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy following BMI sessions and home-based training program (both groups)
Number of subjects: 28
Study 30722727 — intervention group
Group type: COMPARATOR
Intervention: Random orthoses movements (sham group, n = 12)
Number of subjects: 28
Study 30722727 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI-BOLD laterality index assessment (both groups)
Number of subjects: 28
Study 28059417 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 g freeze‐dried highbush blueberry powder per day
Number of subjects: 40
Study 28059417 — intervention group
Group type: COMPARATOR
Intervention: 22 g placebo powder per day
Number of subjects: 40
Study 26229036 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMICAT score derived from semi-automated quantitative measurements of high-risk plaque features
Number of subjects: 260
Study 26229036 — intervention group
Group type: EXPERIMENTAL
Intervention: Model including ROMICAT score, gender, and >50% stenosis
Number of subjects: 260
Study 26229036 — intervention group
Group type: COMPARATOR
Intervention: Model including only gender and >50% stenosis
Number of subjects: 260
Study 24469140 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus mouth rinse
Number of subjects: 0
Study 24469140 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (Control)
Number of subjects: 0
Study 20839040 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted vests
Number of subjects: 6
Study 19039454 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical latanoprost (n=10)
Number of subjects: 20
Study 19039454 — intervention group
Group type: COMPARATOR
Intervention: Lubricant drop (control group, n=10)
Number of subjects: 20
Study 16982402 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 0
Study 16982402 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14600698 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantec‐E irrigation pump with 12 mL of 5.25% NaOCl, followed by 6 mL EDTA 17%, and a final flush with 4 mL 5.25% NaOCl
Number of subjects: 40
Study 14600698 — intervention group
Group type: COMPARATOR
Intervention: Traditional needle and syringe irrigation with the same volumes of NaOCl and EDTA
Number of subjects: 40
Study 14600698 — intervention group
Group type: COMPARATOR
Intervention: Negative control (5 teeth sectioned without instrumentation)
Number of subjects: 40
Study 14600698 — intervention group
Group type: COMPARATOR
Intervention: Positive control (5 teeth instrumented dry without irrigation)
Number of subjects: 40
Study 10916106 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux dialyzers with 175 micro inner diameter polysulfone fibers
Number of subjects: 0
Study 10916106 — intervention group
Group type: COMPARATOR
Intervention: Standard 200 micro polysulfone hollow fiber dialyzers
Number of subjects: 0
Study 8729158 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermagraft (one piece applied weekly for 8 weeks)
Number of subjects: 50
Study 8729158 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound closure methods (Control)
Number of subjects: 50
Study 1574839 — intervention group
Group type: EXPERIMENTAL
Intervention: Jittered stimulus with sawtooth waveform and contrast reversal
Number of subjects: 0
Study 1574839 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarity-specific VEPs
Number of subjects: 0
Study 1574839 — intervention group
Group type: EXPERIMENTAL
Intervention: Polarity VEPs
Number of subjects: 0
Study 1574839 — intervention group
Group type: COMPARATOR
Intervention: Standard VEPs
Number of subjects: 0
Study 3929318 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-alpha-acetylmethadol
Number of subjects: 0
Study 3929318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3929318 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0
Study 29574995 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support with usual education
Number of subjects: 400
Study 29574995 — intervention group
Group type: COMPARATOR
Intervention: Usual education
Number of subjects: 400
Study 27779937 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as Teachers Enhanced intervention
Number of subjects: 82
Study 27779937 — intervention group
Group type: COMPARATOR
Intervention: Parents as Teachers (control) curriculum
Number of subjects: 82
Study 24924703 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised, progressive resistance and functional group training for 3 months (2 times per week for two hours)
Number of subjects: 61
Study 24924703 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity motor placebo activity program
Number of subjects: 61
Study 22835632 — intervention group
Group type: EXPERIMENTAL
Intervention: Single endometrial biopsy regimen (S-EBR)
Number of subjects: 200
Study 22835632 — intervention group
Group type: COMPARATOR
Intervention: Hysteroscopy without endometrial scraping
Number of subjects: 200
Study 20237063 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc treatment (20 mg/d for 10 days)
Number of subjects: 148
Study 20237063 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc treatment plus supplementation (10 mg/d for 3 months after initial treatment)
Number of subjects: 148
Study 20237063 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc treatment (ZT)
Number of subjects: 148
Study 20237063 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc treatment plus supplementation (ZT+S)
Number of subjects: 148
Study 18537187 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF (10 microg/kg/day for 5 days)
Number of subjects: 24
Study 18537187 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 24
Study 15893176 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype 3 encompassing the E670G variant
Number of subjects: 691
Study 15893176 — intervention group
Group type: EXPERIMENTAL
Intervention: E670G variant
Number of subjects: 691
Study 15893176 — intervention group
Group type: COMPARATOR
Intervention: E670G genotypes
Number of subjects: 691
Study 15893176 — intervention group
Group type: COMPARATOR
Intervention: Global haplotype distribution
Number of subjects: 691
Study 14602842 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver age
Number of subjects: 327
Study 10971545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients (n=43)
Number of subjects: 43
Study 10971545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients with DeltaF508 genotype (n=33)
Number of subjects: 43
Study 10971545 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients with other CF genotypes (n=10)
Number of subjects: 43
Study 10971545 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteer control subjects
Number of subjects: 43
Study 8803648 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 0
Study 8803648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1451291 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide gel 5%
Number of subjects: 77
Study 1451291 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical isotretinoin 0.05%
Number of subjects: 77
Study 1451291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle base)
Number of subjects: 77
Study 6548348 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 0
Study 6548348 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine
Number of subjects: 0
Study 6548348 — intervention group
Group type: COMPARATOR
Intervention: Other anti-emetic drugs
Number of subjects: 0
Study 29843553 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous bis-glycinate tablets once daily for eight consecutive weeks
Number of subjects: 187
Study 29843553 — intervention group
Group type: COMPARATOR
Intervention: Ferrous glycine sulfate capsules once daily for eight consecutive weeks
Number of subjects: 187
Study 29436624 — intervention group
Group type: EXPERIMENTAL
Intervention: Lou type equation for warfarin dosing
Number of subjects: 87
Study 29436624 — intervention group
Group type: COMPARATOR
Intervention: Control group (doctor's recommendations)
Number of subjects: 87
Study 27412465 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 148
Study 27412465 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 148
Study 27412465 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study 25179592 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 177
Study 25179592 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 177
Study 22889573 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (6-month supervised program, 3 times a week)
Number of subjects: 140
Study 22889573 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 140
Study 20179126 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component physical activity programme (n=297) including structured physical education lessons, additional lessons, daily activity breaks, and homework.
Number of subjects: 540
Study 20179126 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component physical activity programme (n=297)
Number of subjects: 540
Study 20179126 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=205)
Number of subjects: 540
Study 18048554 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centered care approach
Number of subjects: 25
Study 18048554 — intervention group
Group type: EXPERIMENTAL
Intervention: Context-sensitive, context-informed dialog
Number of subjects: 25
Study 16351361 — intervention group
Group type: EXPERIMENTAL
Intervention: Response compatibility processes (e.g., Implicit Association Test, affective priming with an evaluative decision task)
Number of subjects: 0
Study 16351361 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulus compatibility processes (e.g., semantic priming with a lexical-decision task)
Number of subjects: 0
Study 12160197 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group (weight loss and reduced sodium intake)
Number of subjects: 222
Study 12160197 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 222
Study 10920087 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonal‐F (recombinant human FSH)
Number of subjects: 496
Study 10920087 — intervention group
Group type: COMPARATOR
Intervention: Metrodin HP (highly purified urinary human FSH)
Number of subjects: 496
Study 10920087 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonal‐F
Number of subjects: 496
Study 10920087 — intervention group
Group type: COMPARATOR
Intervention: Metrodin HP
Number of subjects: 496
Study 8873535 — intervention group
Group type: EXPERIMENTAL
Intervention: Bump position (head turned to the contralateral side with a rolled towel placed vertically between the scapulas)
Number of subjects: 105
Study 8873535 — intervention group
Group type: COMPARATOR
Intervention: No bump position (head facing forward with no towel placed in the back)
Number of subjects: 105
Study 8873535 — intervention group
Group type: EXPERIMENTAL
Intervention: Bump position
Number of subjects: 105
Study 8873535 — intervention group
Group type: EXPERIMENTAL
Intervention: More than three needle passes
Number of subjects: 105
Study 1524687 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer pre-brush rinse (0.03% triclosan and 0.125% copolymer)
Number of subjects: 111
Study 1524687 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo pre-brush rinse
Number of subjects: 111
Study 3751955 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed meals with different types of carbohydrate (potato, white bread, rice, spaghetti, lentils and barley)
Number of subjects: 6
Study 3751955 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated meal glycemic index (GI)
Number of subjects: 6
Study 31366053 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g baru almonds (BARU)
Number of subjects: 46
Study 31366053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 46
Study 29159578 — intervention group
Group type: EXPERIMENTAL
Intervention: Autism Program Environment Rating Scale (APERS)
Number of subjects: 0
Study 29159578 — intervention group
Group type: COMPARATOR
Intervention: Professional development program
Number of subjects: 0
Study 26503312 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (240 mg/kg over 12 h)
Number of subjects: 0
Study 26503312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24657122 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY‐CRM booster dose
Number of subjects: 730
Study 24657122 — intervention group
Group type: COMPARATOR
Intervention: MenACWY‐CRM
Number of subjects: 730
Study 24657122 — intervention group
Group type: COMPARATOR
Intervention: MenACWY‐D
Number of subjects: 730
Study 22440819 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETA)
Number of subjects: 76
Study 22440819 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine (SSZ)
Number of subjects: 76
Study 20576842 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 19
Study 20576842 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 17608635 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 203
Study 17608635 — intervention group
Group type: COMPARATOR
Intervention: Routine information preparation (Control)
Number of subjects: 203
Study 16182516 — intervention group
Group type: EXPERIMENTAL
Intervention: MacArthur Competence Assessment Tool‐Clinical Research (MacCAT‐CR)
Number of subjects: 1447
Study 16182516 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative symptoms
Number of subjects: 1447
Study 16182516 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory
Number of subjects: 1447
Study 12685416 — intervention group
Group type: EXPERIMENTAL
Intervention: HbAA pregnant women
Number of subjects: 130
Study 12685416 — intervention group
Group type: EXPERIMENTAL
Intervention: HbAS pregnant women
Number of subjects: 130
Study 12685416 — intervention group
Group type: COMPARATOR
Intervention: Non-pregnant control women
Number of subjects: 130
Study 10072015 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (ADO) infusion (60 microg x kg(‐1) x min(‐1))
Number of subjects: 20
Study 10072015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7735464 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine detection using high-performance liquid chromatography with fluorescence detection
Number of subjects: 0
Study 2252185 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 296
Study 2252185 — intervention group
Group type: COMPARATOR
Intervention: Lateral position
Number of subjects: 296
Study 31391019 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident RPFOA population
Number of subjects: 1295
Study 27699493 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus leucovorin and oxaliplatin
Number of subjects: 0
Study 27699493 — intervention group
Group type: COMPARATOR
Intervention: Standard S‐1 plus cisplatin
Number of subjects: 0
Study 27699493 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 25367150 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 60
Study 25367150 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 60
Study 25367150 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 60
Study 25367150 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60
Study 23543666 — intervention group
Group type: EXPERIMENTAL
Intervention: Vandetanib
Number of subjects: 33
Study 23543666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 21775560 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (daily vitamin C 120 mg, β-carotene 6 mg, vitamin E 30 mg, selenium 100 μg, zinc 20 mg)
Number of subjects: 4447
Study 21775560 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 4447
Study 21775560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4447
Study 20023348 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Muscular Stabilization Techniques (DMST)
Number of subjects: 102
Study 20023348 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (electrotherapy and lumbar strengthening exercises)
Number of subjects: 102
Study 17264975 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric isokinetic resistance training
Number of subjects: 70
Study 17264975 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic resistance training
Number of subjects: 70
Study 14984920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK-MB ratios of 0-1xULN
Number of subjects: 2384
Study 14984920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK-MB ratios of 1-3xULN
Number of subjects: 2384
Study 14984920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK-MB ratios of 3-5xULN
Number of subjects: 2384
Study 14984920 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak CK-MB ratios of 5-10xULN
Number of subjects: 2384